BHepatic encephalopathy
Adjunct
Hepatic encephalopathy
Adjunct
L-ornithine-L-aspartate (LOLA) is a combined drug used in clinical hepatology, distinct from the free amino acid L-ornithine. and in their joint 2014 guideline included LOLA as an adjunct option for overt hepatic encephalopathy in cirrhosis, in addition to lactulose and rifaximin. A Cochrane review in 2018 pooled 36 RCTs and found reduced mortality and improved psychometric tests with very low certainty and an uncertain result; the authors noted risk of bias in part of the studies. Self-administered consumer L-ornithine from iHerb does not substitute the hepatologist's prescription; the decision on LOLA is taken by the doctor after assessing the encephalopathy grade and liver function.
Sources
ICD-10: K72.9 · ICD-11: DB99.5